BCHE and Alzheimer disease: Hence, although 12, the only acetylated nucleoside, did not show promising cholinesterase inhibition, it became the first nucleoside-based molecule with metal chelating properties and, therefore, became a starting point for the investigation of structural modifications that could lead to the desired dual-target compounds against AD.